Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFUL.L Regulatory News (FUL)

  • There is currently no data for FUL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

6 Sep 2017 12:40

RNS Number : 9964P
Fulham Shore PLC (The)
06 September 2017
 

6 September 2017

 

The Fulham Shore plc

("Fulham Shore", the "Company" or "Group")

 

Director/PDMR shareholding

 

The Fulham Shore plc (AIM: FUL) has been informed that Nicholas Wong, Finance Director of the Company, has today purchased 35,500 ordinary shares in the Company ("Ordinary Shares") at a price of 13.4p per share. Following this purchase, Mr Wong now has a total beneficial interest in 8,786,093 Ordinary Shares, equivalent to 1.54% of the Company's issued share capital.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nicholas Wong

2

Reason for the notification

a)

Position/status

Finance Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

The Fulham Shore plc

b)

LEI

n/a

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1p each in The Fulham Shore plc

 

Identification code (ISIN) for The Fulham Shore plc ordinary shares: GB00B9F8VG44

b)

Nature of the transaction

Purchase of shares

 

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

13.4p

35,500

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

06 September 2017

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

The information set out in this announcement is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

 

Contacts:

 

The Fulham Shore plc

www.fulhamshore.com

David Page

 

Telephone: 020 7796 4133

Allenby Capital Limited

Nick Naylor / Jeremy Porter / James Reeve

 

Tel: 020 3328 5656

 

Hudson Sandler - Financial PR

Alex Brennan / Lucy Wollam

fulhamshore@hudsonsandler.com

Telephone: 020 7796 4133

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKADNDBKDPCK
Date   Source Headline
10th Jan 20087:01 amRNSProposed Board Changes
20th Dec 20075:35 pmRNSResult of AGM
26th Nov 20077:01 amRNSFinal Results
15th Nov 20077:01 amRNSNotice of Results/Trdg Update
6th Nov 20077:01 amRNSOpening of new US office
11th Oct 20077:01 amRNSContract Win
7th Sep 20077:01 amRNSRe Alliance
3rd Sep 20074:13 pmRNSDirector/PDMR Shareholding
20th Aug 20074:09 pmRNSDirector/PDMR Shareholding
17th Aug 20074:37 pmRNSAIM Rule 26
15th Aug 20077:01 amRNSTrading Update
17th May 20077:01 amRNSInterim Results
18th Apr 20074:46 pmRNSDirector/PDMR Shareholding
12th Apr 20071:40 pmRNSEGM Statement
19th Mar 200711:28 amRNSPlacing and Acquisition
21st Feb 20077:00 amRNSCompletion of Earn Out
21st Dec 20069:29 amRNSTotal Voting Rights
18th Dec 200612:52 pmRNSResult of AGM
15th Nov 20062:06 pmRNSDirector/PDMR Shareholding
9th Nov 20067:01 amRNSFinal Results
2nd Aug 20067:00 amRNSDirector/PDMR Shareholding
12th May 20067:01 amRNSEdinburgh Office Opens
9th May 20067:01 amRNSInterim Results
12th Apr 200610:30 amRNSContract with Celtic Pharma
5th Apr 20067:01 amRNSNanoCarrier Partnership
7th Mar 20067:01 amRNSBoard Appointment
9th Feb 20067:01 amRNSAcquisition of Quadramed Ltd
19th Dec 200512:09 pmRNSAGM Statement
14th Nov 200512:18 pmRNSDirector/PDMR Shareholding
9th Nov 20057:00 amRNSPreliminary Results
14th Sep 20057:02 amRNSTrading Update
18th May 20057:01 amRNSSyngenta Biopharma Agreement
18th May 20057:00 amRNSInterim Results
5th May 200512:20 pmRNSNotice of Interim Results
1st Mar 20057:03 amRNSPresent at Networking Evening
25th Jan 20057:00 amRNSPresentation with Addex
6th Jan 20057:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.